Reaction
Arteriovenous Fistula Occlusion reporting signals
As of the last recalculation, Arteriovenous Fistula Occlusion appears in 174 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 297.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 23 | 297.4 | 298.0 |
| Dalteparin Sodium | 21 | 269.9 | 270.5 |
| Paricalcitol | 21 | 202.1 | 202.4 |
| Sevelamer Carbonate | 9 | 98.8 | 98.8 |
| Epoetin Alfa | 9 | 95.8 | 95.9 |
| Loperamide Hydrochloride And Dimethicone | 22 | 93.8 | 93.9 |
| Eculizumab | 32 | 86.1 | 86.1 |
| Patiromer | 9 | 82.0 | 82.0 |
| Cinacalcet Hydrochloride | 25 | 74.8 | 74.8 |
| Dexlansoprazole | 22 | 72.1 | 72.1 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 33.1 | 33.1 |